SHORT REVIEW
Εvidence the pathogenesis of chronic obstructive pulmonary disease at the cellular level: Potential therapeutic benefits of phosphodiesterase inhibitors -4
More details
Hide details
Publication date: 2021-08-02
Pneumon 2005;18(2):174-183